The switch to natural food colouring

Mounting concern over harmful effects of synthetic additives drives demand for natural colourings.

Taming the wild side

The RTD beverage business is only going to get tougher, but Traditional Food Corporation is geared for competition, writes MIA AUREUS.

Ascend starts new compounding operations

Ascend Performance Materials Inc. is announcing the start of a new compounding line in Pensacola, Florida.

Arburg launches additive manufacturing system

A day before K 2013 opens, Arburg announced its entry into additive manufacturing through its new unique Arburg Plastic Freeforming (AKF) system.

Pall opens new life sciences centre in Shanghai

The opening of the Shanghai Life Sciences Centre of Excellence is another milestone in Pall’s development in China

SK Hynix opens a flash R&D center in Taiwan

The company will strengthen global R&D competence and customer support by adding the R&D center in Taiwan

Restoring the sense of touch during laparoscopy

A team of engineers and doctors has developed a new wireless capsule that can give surgeons back their sense of touch when performing minimally invasive surgery

3,218 exhibitors show their innovative power at K 2013

K 2013 opens today, 16 October; 3,218 exhibitors from 59 countries present their latest developments in all segments of the industry.

Biotech event this November in Beijing

Washington Governor Jay Inslee to keynote the BIO Convention in China 2013

Anesthesiologist do’s and don’ts in ‘Choosing Wisely’ initiative

American Society of Anesthesiologists releases list of dentifies five targeted, evidence-based recommendations that can support conversations between patients and physicians about what care is really necessary

Technological breakthrough for skin regeneration

Researchers demonstrate new multimodal optical microscopy technology that when coupled with advanced image co-registration algorithms, can account for soft-tissue deformations that may occur over the time-course of weeks and months

NMT partners with Stelin in anti-cancer drug clinical trial

NanoMaterials Technology (NMT) Singapore signs clinical trial material supply agreement for anti-cancer drug with CHRISTUS Stehlin Foundation for Cancer Research